Hon MICHAEL WOODHOUSE (National): Thank you, Mr Chair. Mr Seymour's questions around the breadth of the bill was one of my questions, and the Minister has answered that satisfactorily. This is not just about Pfizer; it's about all of the vaccines that have been approved so far, although I note that Pfizer was the only one mentioned in the regulatory impact statement, which is rather unusual and probably reflects a degree of influence of, and breadth of the use of, that vaccine.